BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29594732)

  • 1. Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.
    Wang X; Pang L; Zhang Y; Xu J; Ding D; Yang T; Zhao Q; Wu F; Li F; Meng H; Yu D
    Neurochem Res; 2018 Apr; 43(4):938-947. PubMed ID: 29594732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K/Akt/mTOR signaling pathway.
    Zheng M; Chen M; Liu C; Fan Y; Shi D
    J Ethnopharmacol; 2021 Feb; 266():113451. PubMed ID: 33049346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervention effect of Lycium barbarum polysaccharide on lead-induced kidney injury mice and its mechanism: A study based on the PI3K/Akt/mTOR signaling pathway.
    Xie W; Chen HG; Chen RH; Zhao C; Gong XJ; Zhou X
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117197. PubMed ID: 37722516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
    Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
    Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
    Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycium barbarum polysaccharide protects against oxygen glucose deprivation/reoxygenation-induced apoptosis and autophagic cell death via the PI3K/Akt/mTOR signaling pathway in primary cultured hippocampal neurons.
    Yu Y; Wu X; Pu J; Luo P; Ma W; Wang J; Wei J; Wang Y; Fei Z
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1187-1194. PubMed ID: 29183728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.
    Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z
    Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
    Bao XQ; Kong XC; Qian C; Zhang D
    Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
    Ge H; Yan Z; Zhu H; Zhao H
    Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of miR-199a on autophagy by targeting glycogen synthase kinase 3β to activate PTEN/AKT/mTOR signaling in an MPP
    Ba RQ; Liu J; Fan XJ; Jin GL; Huang BG; Liu MW; Yang JS
    Neurol Res; 2020 Apr; 42(4):308-318. PubMed ID: 32151238
    [No Abstract]   [Full Text] [Related]  

  • 11. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
    Domanskyi A; Geissler C; Vinnikov IA; Alter H; Schober A; Vogt MA; Gass P; Parlato R; Schütz G
    FASEB J; 2011 Sep; 25(9):2898-910. PubMed ID: 21593433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson's disease.
    Song J; Liu L; Li Z; Mao T; Zhang J; Zhou L; Chen X; Shang Y; Sun T; Luo Y; Jiang Y; Tan D; Tong X; Dai F
    BMC Med; 2022 Oct; 20(1):412. PubMed ID: 36303171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bergenin Ameliorates MPTP-Induced Parkinson's Disease by Activating PI3K/Akt Signaling Pathway.
    Ji Y; Wang D; Zhang B; Lu H
    J Alzheimers Dis; 2019; 72(3):823-833. PubMed ID: 31658061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
    Gu PS; Moon M; Choi JG; Oh MS
    J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lycium barbarum polysaccharides on cell signal transduction pathways.
    Qi Y; Duan G; Fan G; Peng N
    Biomed Pharmacother; 2022 Mar; 147():112620. PubMed ID: 35032768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.